JPX Equity Snapshot
190A Weekly Equity Report
CHORDIA THERAPEUTICS INC
What the company does
Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. Chordia Therapeutics Inc. was incorporated in 2017 and is based in Fujisawa, Japan.
What the weekly tape is saying
190A closed the latest completed week at 97.00 JPY. The 4-week return is -17.1% and the 12-week return is -23.0%. Trend Signal is inactive, Market Dynamics is -0.75. Setup signature: Risk-first tape with a 10/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 122.2 JPY
- Vs Trend Line
- -20.6%
- Fair Value
- 233.0 JPY
- Vs Fair Value
- -58.4%
- 52W High
- 238.0 JPY
- 52W Low
- 95.00 JPY
- Drawdown
- -59.2%
- Range Position
- 1.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 8
- 52W Active Breadth
- 15.4%
- Sector Scope
- JP Healthcare
- Sector Rank
- 183 of 223
- Sector Percentile
- 18.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
JP Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.3%
- Avg 4W
- -3.4%
- Trend Breadth
- 27.0%
- Positive MD
- 28.0%
JP Biotechnology
- Tracked Peers
- 48
- 4W Rank
- 28 of 48
- Avg 1W
- -6.1%
- Avg 4W
- -16.7%
- Trend Breadth
- 12.5%
- Positive RS
- 2.1%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.75
- 4W MD Change
- -223.0%
- Relative Strength
- -48.60
- 4W RS Change
- -20.4%
- Expectation
- Negative
- Probability
- 34.40%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 3.7M
- 13W Average
- 4.6M
- 52W Average
- 5.4M
- Vs 13W
- 0.8x
- Vs 52W
- 0.7x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 8.8%
- 52W Volatility
- 9.2%
- Upside Weeks
- 18
- Downside Weeks
- 30
- Downside Breadth
- 57.7%
- Avg Gain / Loss
- 6.7% / -6.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- JPX
- Country
- JP
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- JPY
- Market Cap
- 8.2B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 97.00 JPY | -6.7% | 122.2 JPY | 233.0 JPY | -0.75 | -48.60 | 3.7M | Off |
| 5 Jun 2026 | 104.0 JPY | -4.6% | 122.5 JPY | 234.4 JPY | -0.41 | -47.01 | 3.9M | Off |
| 29 May 2026 | 109.0 JPY | -3.5% | 122.6 JPY | 235.6 JPY | 0.03 | -45.76 | 3.0M | Off |
| 22 May 2026 | 113.0 JPY | -3.4% | 122.7 JPY | 236.9 JPY | 0.35 | -42.70 | 4.1M | On |
| 15 May 2026 | 117.0 JPY | -26.9% | 122.8 JPY | 238.1 JPY | 0.61 | -40.39 | 11.9M | On |
| 8 May 2026 | 160.0 JPY | 3.9% | 122.7 JPY | 239.3 JPY | 0.72 | -22.10 | 2.4M | On |
| 1 May 2026 | 154.0 JPY | 2.0% | 121.4 JPY | 240.1 JPY | 0.68 | -22.60 | 3.1M | On |
| 24 Apr 2026 | 151.0 JPY | 6.3% | 120.5 JPY | 241.0 JPY | 0.66 | -25.93 | 6.2M | On |
| 17 Apr 2026 | 142.0 JPY | 10.9% | 120.1 JPY | 241.9 JPY | 0.68 | -30.49 | 4.3M | On |
| 10 Apr 2026 | 128.0 JPY | 2.4% | 120.3 JPY | 242.9 JPY | 0.70 | -37.35 | 2.7M | On |
| 3 Apr 2026 | 125.0 JPY | -5.3% | 120.9 JPY | 244.2 JPY | 0.78 | -36.22 | 4.9M | On |
| 27 Mar 2026 | 132.0 JPY | 4.8% | 122.7 JPY | 245.4 JPY | 0.90 | -34.63 | 5.0M | Off |
| 20 Mar 2026 | 126.0 JPY | -2.3% | 124.3 JPY | 246.6 JPY | 0.96 | -39.06 | 4.7M | Off |
| 13 Mar 2026 | 129.0 JPY | -1.5% | 126.1 JPY | 248.0 JPY | 0.93 | -39.57 | 4.5M | Off |